This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Merck Floats Vioxx Re-Stock

For its part, Merck has suggested that a relaunch may make sense due to the unique characteristics of Vioxx. For starters, the company has always pointed to Vioxx as the only Cox-2 inhibitor that has been labeled as safer on the stomach than older painkillers. In addition, it is the only Cox-2 drug that can be used by patients with certain allergies. Some patients have been pleading for a return of the drug despite its cardiac risks.

Even so, Merck could face an uphill battle if it actually decides to pursue the drug's return.

"Given that Merck decided voluntarily to withdraw Vioxx, the possibility of re-launching was always present," wrote Lehman Brothers analyst Anthony Butler, who has a neutral rating on the stock. But, "We believe that there are likely to be multiple hurdles for Merck to overcome should they decide to re-launch."

Prior to its recall, Vioxx ranked as one of the most heavily marketed -- and prescribed -- drugs in the country. It once generated about $2.5 billion in annual sales.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
MRK $60.10 0.00%
PFE $34.36 0.00%
AAPL $131.39 0.00%
FB $80.48 0.00%
GOOG $542.51 0.00%

Markets

DOW 18,285.74 +0.34 0.00%
S&P 500 2,130.82 +4.97 0.23%
NASDAQ 5,090.7940 +19.0510 0.38%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs